BAYER AG |
Market Closed -
Other stock markets
|
After market 03:59:40 pm | |||
| 27.58 EUR | -2.85% |
|
27.56 | -0.07% |
| May. 20 | BAYER AG : JP Morgan reiterates its Neutral rating | ZD |
| May. 17 | BAYER AG : UBS remains Neutral | ZD |
ETFs positioned on Bayer AG
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 9.77% | 70 M€ | -.--% | - | |
| 5.71% | 2 M€ | +13.56% | - | |
| 4.28% | 962 M€ | -.--% | - | |
| 4.10% | 0 M€ | 0.00% | - | |
| 3.33% | 18 M€ | +7.68% | ||
| 3.03% | 79 M€ | -.--% | ||
| 1.91% | 131 M€ | -.--% | - | |
| 1.63% | 264 M€ | +13.50% | - | |
| 1.52% | 17 M€ | +8.31% | - | |
| 0.79% | 6 M€ | -.--% | - | |
| 0.72% | 17 M€ | 0.00% | ||
| 0.53% | 6 M€ | -.--% | ||
| 0.42% | 1,083 M€ | +3.43% | ||
| 0.31% | 7 M€ | +4.98% | - | |
| 0.30% | 10 M€ | -3.35% | - | |
| 0.28% | 75 M€ | +6.58% | - | |
| 0.21% | 32 M€ | +1.27% | - | |
| 0.18% | 32 M€ | +6.91% | - | |
| 0.14% | 29 M€ | +8.37% | - | |
| 0.13% | 283 M€ | +22.07% | ||
| 0.09% | 607 M€ | +0.05% | - | |
| 0.09% | 1,166 M€ | +0.26% | - | |
| 0.09% | 0 M€ | 0.00% | - |
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
Pharmaceuticals
Calendar
2024-08-06
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
28.4
EUR
Average target price
36.9
EUR
Spread / Average Target
+29.97%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -17.98% | 30.23B | |
| +38.69% | 723B | |
| +34.28% | 595B | |
| -4.49% | 369B | |
| +20.24% | 332B | |
| +2.12% | 282B | |
| +17.02% | 244B | |
| +9.31% | 208B | |
| -5.07% | 205B | |
| -0.35% | 168B |
- Stock Market
- Equities
- BAYN Stock
- Funds and ETFs Bayer AG
